Literature DB >> 6371894

Cellular proliferation in atherosclerosis and hypertension.

S M Schwartz, R Ross.   

Abstract

We have tried to compare the proliferative responses seen in two vascular diseases: atherosclerosis and hypertension. Both diseases involve endothelial injury and proliferation, but our knowledge of this phenomenon is just beginning to emerge. In atherosclerosis the best evidence is that denudation does not occur in the normal young animal. Man, however, ages over a much longer time than our usual animal models, and the study of denudation during the chronic progression of atherosclerotic lesions remains to be done. We need to consider the possibility that repetitive, small lesions may occur at sites of endothelial turnover. We also need to know more about the possible role of nondenuding injuries, including death of endothelial cells in situ and the apparent increased stickiness of endothelial cells and monocytes during the early stages of hypercholesterolemia. The role of endothelial injury in hypertension also needs more study. We know that extensive denudation and thrombosis occur in small vessels subjected to high blood pressure. It is highly probable that release of PDGF occurs at these sites, possibly accounting for the characteristic hyperplasia seen in malignant hypertension. Whether this process is related to the more subtle changes in vessel wall mass seen in chronic hypertension remains unknown. Finally, there are remarkable differences in the proliferative behavior of the smooth muscle cells themselves in these two diseases. Hypertensive vascular disease is, in large part, a disease of the media. Atherosclerosis is characterized by intimal hyperplasia. Injury results in migration of smooth muscle cells from the media and cell division in the intima. It is possible to identify chemotactic factors using putative atherosclerosis risk factors or normal components of serum. This has already been done for one component of lesion formation, PDGF, and there is a report of a monocyte chemotactic factor released by smooth muscle cells. Factors released by other components of lesions may be of considerable interest. In contrast, changes in hypertension occur within a more orderly preservation of vessel wall structure. The wall thickens, but this occurs by increased synthesis of cell mass in the media. The cells themselves do not even divide, but they undergo a form of amitotic replication of their DNA.(ABSTRACT TRUNCATED AT 400 WORDS)

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 6371894     DOI: 10.1016/0033-0620(84)90010-0

Source DB:  PubMed          Journal:  Prog Cardiovasc Dis        ISSN: 0033-0620            Impact factor:   8.194


  13 in total

1.  Alterations in expression of myosin and myosin light chain kinases in response to vascular injury.

Authors:  P J Gallagher; Y Jin; G Killough; E K Blue; V Lindner
Journal:  Am J Physiol Cell Physiol       Date:  2000-10       Impact factor: 4.249

2.  Modulation of response to adenosine in vascular smooth muscle cells cultured in defined medium.

Authors:  Y M Xiong; S Z Xu; L L Slakey
Journal:  In Vitro Cell Dev Biol       Date:  1991-05

3.  Protein expression changed by nicotine in rat vascular smooth muscle cells.

Authors:  Z Wang; W Wu; X Fang; Y Wang; C Xiao; R Zhao; L Wang; Z Qiao
Journal:  J Physiol Biochem       Date:  2007-06       Impact factor: 4.158

4.  Mechanical stretch augments PDGF receptor beta expression and protein tyrosine phosphorylation in pulmonary artery tissue and smooth muscle cells.

Authors:  Y Tanabe; M Saito; A Ueno; M Nakamura; K Takeishi; K Nakayama
Journal:  Mol Cell Biochem       Date:  2000-12       Impact factor: 3.396

5.  Human aortic fibrolipid lesions. Progenitor lesions for fibrous plaques, exhibiting early formation of the cholesterol-rich core.

Authors:  T M Bocan; J R Guyton
Journal:  Am J Pathol       Date:  1985-08       Impact factor: 4.307

6.  Blood pressure regulates platelet-derived growth factor A-chain gene expression in vascular smooth muscle cells in vivo. An autocrine mechanism promoting hypertensive vascular hypertrophy.

Authors:  N Negoro; Y Kanayama; M Haraguchi; N Umetani; M Nishimura; Y Konishi; J Iwai; M Okamura; T Inoue; T Takeda
Journal:  J Clin Invest       Date:  1995-03       Impact factor: 14.808

7.  Inhibitory effects of total saponin from Korean Red Ginseng on [Ca(2+)]i mobilization through phosphorylation of cyclic adenosine monophosphate-dependent protein kinase catalytic subunit and inositol 1,4,5-trisphosphate receptor type I in human platelets.

Authors:  Jung-Hae Shin; Hyuk-Woo Kwon; Hyun-Jeong Cho; Man Hee Rhee; Hwa-Jin Park
Journal:  J Ginseng Res       Date:  2015-03-28       Impact factor: 6.060

8.  Inhibitory Effects of Cytosolic Ca(2+) Concentration by Ginsenoside Ro Are Dependent on Phosphorylation of IP3RI and Dephosphorylation of ERK in Human Platelets.

Authors:  Hyuk-Woo Kwon; Jung-Hae Shin; Dong-Ha Lee; Hwa-Jin Park
Journal:  Evid Based Complement Alternat Med       Date:  2015-08-19       Impact factor: 2.629

9.  Tungstate-targeting of BKαβ1 channels tunes ERK phosphorylation and cell proliferation in human vascular smooth muscle.

Authors:  Ana Isabel Fernández-Mariño; Pilar Cidad; Delia Zafra; Laura Nocito; Jorge Domínguez; Aida Oliván-Viguera; Ralf Köhler; José R López-López; María Teresa Pérez-García; Miguel Ángel Valverde; Joan J Guinovart; José M Fernández-Fernández
Journal:  PLoS One       Date:  2015-02-06       Impact factor: 3.240

10.  Enhanced expressions of endothelin-converting enzyme and endothelin receptors in human colonic tissues of Crohn's disease.

Authors:  Takehisa Suekane; Yoshihiro Ikura; Junko Arimoto; Masashi Nakagawa; Chizuko Kitabayashi; Takahiko Naruko; Toshio Watanabe; Yasuhiro Fujiwara; Nobuhide Oshitani; Kiyoshi Maeda; Kazuhiko Tanzawa; Kosei Hirakawa; Tetsuo Arakawa; Makiko Ueda
Journal:  J Clin Biochem Nutr       Date:  2008-03       Impact factor: 3.114

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.